On April 22, 2024, regarding the case Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc. et al., case number 23-768, the US Supreme Court denied Vanda’s request to review an appeals court decision that invalidated several patents for Hetlioz (tasimelteon). Teva is represented by John Christopher Rozendaal, Deirdre Wells, and William Milliken from Sterne Kessler Goldstein & Fox.
Read
Full Article
Subscription Required
Related Professionals
Related Industries
Related Services
Stay in the Know
Receive insights from the most respected practitioners of IP law, straight to your inbox.
Subscribe for Updates